Drug Discovery
Did you every consider that your most potent molecule may not be the one you should develop? That compound with picomolar binding affinity may be far too unstable or insoluble or metabolically labile to ever make it to market.
PharmaDirections designs and manages material-efficient lead selection, ADME modeling and "druggability" studies to assist in candidate selection or to elucidate potential roadblocks in developing specific molecules. Parameters that are evaluated include:
- ADME Prediction
- Duggability
- New Intellectual Property
- Permeability/Bioavailability
- Pharmacokinetics
- Biopharmaceutics
- Toxicology Prediction
- In-Vivo testing